Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial
Simrat Gill(University Hospitals Birmingham NHS Foundation Trust), Diederick E. Grobbee(University Medical Center Utrecht), Karina V Bunting, A. John Camm(St George's, University of London), Mary Stanbury(West Midlands Police), Julia Kurps(The Hyve (Netherlands)), Andreas Karwath(Cancer Research UK Clinical Trials Unit), Otilia Țica, Folkert W. Asselbergs, Andrey Barsky(Cancer Research UK Clinical Trials Unit), Marinus J.C. Eijkemans(Erasmus University Rotterdam), Amos Folarin(King's College London), Richard Dobson(University of London), Georgios V. Gkoutos(University of Cambridge), Sandra Haynes(West Midlands Police), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Xin Guan(University of Birmingham)
Cited by 38
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k